Down-regulation of heat-shock protein 70 (HSP-70) correlated with responsiveness to neoadjuvant aromatase inhibitor therapy in breast cancer patients. [electronic resource]
- Anticancer research Sep 2010
- 3465-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1791-7530
Aged Androstadienes--therapeutic use Antineoplastic Agents--therapeutic use Aromatase Inhibitors--therapeutic use Breast Neoplasms--drug therapy Down-Regulation Drug Resistance, Neoplasm--physiology Female HSP70 Heat-Shock Proteins--biosynthesis Humans Immunohistochemistry Ki-67 Antigen--biosynthesis Letrozole Neoadjuvant Therapy Nitriles--therapeutic use Randomized Controlled Trials as Topic Triazoles--therapeutic use